Literature DB >> 11252405

Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate.

M Stoltenberg1, M Martiny, K Sørensen, J Rungby, K A Krogfelt.   

Abstract

BACKGROUND: Bismuth-containing drugs are widely used in the treatment of Helicobacter pylori associated peptic ulcer. The mechanism of action of bismuth salts is, however, not fully understood, and at present no histochemical techniques for the demonstration of bismuth in H. pylori are available. The aims were to present a histochemical method for the detection of bismuth in H. pylori and to demonstrate bismuth uptake in H. pylori after in vitro exposure to bismuth citrate.
METHODS: H. pylori cultures (the strain used in this study was CCUG 17874), were exposed to bismuth citrate at different concentrations (0, 4.6, 80, 200 microM) and for different lengths of time (0 min, 15 min, 1 h, 24 h, 48 h). The samples were fixed in glutaraldehyde, centrifuged, and exposed to autometallographic (AMG) development in order to detect bismuth histochemically.
RESULTS: A detailed protocol on the AMG bismuth technique on H. pylori exposed to bismuth in vitro is given. This method results in easily detectable AMG grains of silver enhanced bismuth particles at the electron microscopical level, and shows that bismuth accumulates in H. pylori, predominantly near the wall of the bacteria. Bismuth uptake is followed by bacterial degeneration.
CONCLUSION: The present technique with its ability to trace bismuth constitutes a valuable tool in the efforts of clarifying the mechanism of action of bismuth on H. pylori, and supports the notion that bismuth has an antimicrobial activity in itself.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11252405

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Microbial genomics and the periodic table.

Authors:  Lawrence P Wackett; Anthony G Dodge; Lynda B M Ellis
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

2.  Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.

Authors:  Evrim Kahramanoğlu Aksoy; Ferdane Pirinçci Sapmaz; Zeynep Göktaş; Metin Uzman; Yaşar Nazlıgül
Journal:  Med Princ Pract       Date:  2017-11-03       Impact factor: 1.927

3.  Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells.

Authors:  Yifan Hong; Yau-Tsz Lai; Godfrey Chi-Fung Chan; Hongzhe Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

4.  Metabolism of bismuth subsalicylate and intracellular accumulation of bismuth by Fusarium sp. strain BI.

Authors:  Anthony G Dodge; Lawrence P Wackett
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

5.  The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.

Authors:  Sebahat Basyigit; Ayse Kefeli; Ferdane Sapmaz; Abdullah Ozgür Yeniova; Zeliha Asilturk; Murat Hokkaomeroglu; Metin Uzman; Yasar Nazligul
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

6.  The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.

Authors:  Michael V Bland; Salim Ismail; Jack A Heinemann; Jacqueline I Keenan
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.